Galectin 3 — a novel biomarker for chronic heart failure in the patients with ischemic heart disease and concomitant gastroesophageal reflux disease
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 2
Abstract
Objective — to study the role of the biomarker for chronic heart failure (CHF) Galectine 3 (Gal 3) in patients with IHD and concomitant gastroesophageal reflux disease (GERD). Materials and methods. The study involved 100 patients. The first group included 60 patients (43 male (71.7 %), 17 female (28.3 %)) aged 42 to 60 years old (mean (53.79 ± 3.9) years old) with IHD and concomitant nonerosive GERD form. Second group consisted of 40 patients (28 male (70 %), 12 female (30 %)) aged 39 to 60 years old (mean (53.0 ± 4.6) years old) with IHD and without concomitant pathologies. Control group included 20 healthy participants, matching by age (mean (47 ± 6.1) years old) and gender (7 male (35 %), 13 female (65 %)). IHD diagnosis was made according to ICD 10, Unified clinical protocol for primary, secondary and tertiary care «Stable ischemic heart disease», 2013 European Society of Cardiology guidelines on the management of stable coronary artery disease; GERD diagnosis was made according to ICD 10 and The Montreal definition and classification of gastroesophageal reflux disease (2006). BP was measured by the Scipione Riva-Rocci/Korotkoff method using Microlife BP AG1—20 sphygmomanometer (Switzerland) after 10 minute rest in sitting and supine positions to measure systolic BP. Quantitative measurement of human Gal 3 was performed using enzyme-linked immunosorbent assay «Galectine 3» produced by Bender Systems (Austria). All collected data were entered into the electronic database; Statistical treatment was performed with variation and nonparametric biomedical statistics using Excel for Windows, Statistica 6.0 and SPSS Statistics statistical software. Statistical significance was determined using Student’s t-test and Wilcoxon signed-rank test. The difference in results was considered statistically significant with P-value < 0.05. Results and discussion. The obtained results showed that Gal 3 levels were significantly higher in patients with stable angina pectoris of III functional class (FC) compared to both FC II and FC I. Besides, the measurements in both study groups demonstrated that the stage and severity of the essential hypertension significantly affect the Gal 3 levels. The significant increase in Gal 3 levels has been found in patients with degree IIA CHF as compared with both patients with degree 0 and degree 1 CHF, which is evidence for more pronounced heart failure in these patients. Whereas Gal 3 levels in patients with I degree CHF were significantly lower, than in the subjects with CHF of II A degree, but significantly higher, than in patients with CHF of 0 degree in both study groups. Conclusions. It is reasonable to use Gal 3 biomarker to determine severity of heart failure in patients with cardiovascular diseases, as well in patients with other morbidities accompanied by the development of chronic heart failure.
Authors and Affiliations
O. A. Oparin, A. S. Vnukova
Keywords
Related Articles
- EP ID EP632184
- DOI 10.30978/UTJ2019-2-63
- Views 95
- Downloads 0
Sarcopenia as a risk factor for chronic noncommunicable diseases
The article presents the summary of data related to the modern diagnosis of sarcopenia and management of patients with this disease. The actuality of the problem has been demonstrated, as well the difficulties of sarcope...
Correlation between G894T polymorphism eNOS gene and development of periodontal pathology in patients with bronchialcardiac diseases
Objective — to establish possible connection between eNOS gene G894T polymorphism with a risk of pathology developing in the periodontal patients against the background of COPD comorbid with CHD. Materials and methods. T...
Investigation of a new indicator of autoimmune accumulation in the genesis of type I diabetes mellitus
Objective — the search for the new marker of autoimmune accumulation in the genesis of type I diabetes mellitus (DM-1). Materials and methods. With the use of immune enzymatic assay, investigations have been performed of...
The improvement of the efficiency of treatment of hypertension and obesity by individual correction of the eating behavior
Objective — to improve the efficiency of treatment and secondary prevention of hypertension (H) and obesity by individual correction of the eating behavior (EB) against the background of standard therapy. Materials and m...
The circadian rhythms of 6-Sulfatoxymelatonin urine excretion in patients with knee osteoarthrosis
Оbjective — to establish the peculiarities of the circadian rhythms of 6-sulfatoxymelatonin (6-SMT) urine excretion in patients with knee osteoarthrosis (OA) depending on age, gender, duration and stage of the disease. M...